每经AI快讯,4月27日,艾尔建美学公众号宣布,公司旗下产品保妥适®(注射用A型肉毒毒素)用于暂时性改善成人与额肌活动相关的中度至重度额纹适应症,正式获得国家药监局(NMPA)上市批准。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.